causal
Industry Redundancy Duplicates Trial Capacity
Externalization has trade-offs and creates redundancy, because biotechs preparing to launch must build up duplicate capacity to run trials efficiently, even though the trend has some benefits.
causalpending
Speaker
AlexEvidence Quote
“people having to build up redundant capacity to run and execute trials in an efficient way.”
Source
Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]— Invest Like the BestCreated: 11/14/2026, 6:42:06 AM
Your notes
Loading notes...